Home > Insider Trading > Filing (0001666071-21-000048)

Filing Details

Accession Number:: 0001666071-21-000048
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-04-05 20:15:35
Reporting Period:: 2021-04-01

Accepted Time:: 2021-04-05 20:15:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1666071	Cardlytics Inc.	CDLX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1617486	D. Scott Grimes	C/O Cardlytics, Inc. 675 Ponce De Leon Avenue Ne, Suite 6000 Atlanta GA 30308		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-01	14,919	$0.00	251,827	No	4	M	Direct
Common Stock	Disposition	2021-04-05	335	$111.23	88,777	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-04-05	800	$112.48	87,977	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-04-05	165	$113.31	87,812	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-04-05	200	$114.68	87,612	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-04-05	300	$116.85	87,312	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-04-05	200	$118.43	87,112	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Disposition	2021-04-01	14,919	$0.00	14,919	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
44,759			No	4	M	Direct

Footnotes

Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $111.00 to $111.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (6), (7), (8), and (9) to this Form 4.
The reportable securities are held by the GRAT.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $112.06 to $112.82, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $113.08 to $113.37, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $114.63 to $114.72, inclusive.
The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $116.43 to $117.41, inclusive.
The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.